Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study

BACKGROUND: With previously established efficacy of aripiprazole once-monthly injectable formulation (AOM) in pre-registration randomized controlled trials, the current study was designed to evaluate its effectiveness in patients treated for schizophrenia in regular clinical settings in Canada. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustafa, Sally, Bougie, Joanna, Miguelez, Maia, Clerzius, Guerline, Rampakakis, Emmanouil, Proulx, Jean, Malla, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469112/
https://www.ncbi.nlm.nih.gov/pubmed/30991969
http://dx.doi.org/10.1186/s12888-019-2103-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469112/
https://www.ncbi.nlm.nih.gov/pubmed/30991969
http://dx.doi.org/10.1186/s12888-019-2103-x

Ejemplares similares